BioLife Solns Stock (NASDAQ:BLFS), Analyst Ratings, Price Targets, Predictions

The latest price target for BioLife Solns (NASDAQ: BLFS) was reported by Jefferies on April 4, 2024. The analyst firm set a price target for $22.00 expecting BLFS to rise to within 12 months (a possible 21.21% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for BioLife Solns (NASDAQ: BLFS) was provided by Jefferies, and BioLife Solns initiated their buy rating.

The last upgrade for BioLife Solutions Inc happened on April 25, 2022 when Oppenheimer raised their price target to $28. Oppenheimer previously had a perform for BioLife Solutions Inc.

The last downgrade for BioLife Solutions Inc happened on May 14, 2021 when Benchmark changed their price target from N/A to N/A for BioLife Solutions Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioLife Solns, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioLife Solns was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.

While ratings are subjective and will change, the latest BioLife Solns (BLFS) rating was a initiated with a price target of $0.00 to $22.00. The current price BioLife Solns (BLFS) is trading at is $18.15, which is within the analyst’s predicted range.